Table: Torii Pharmaceutical - 6-MTH parent results
Jul 31 (Reuters)-
Torii Pharmaceutical Co Ltd
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
6 months ended 6 months ended Year to
Jun 30, 2020 Jun 30, 2019 Dec 31, 2020
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 19.86 20.68 40.90
(-4.0 pct) (-32.3 pct) (-4.9 pct)
Operating 2.74 290 mln 3.70
(+841.3 pct) (-86.2 pct) (+158.6 pct)
Recurring 2.90 402 mln 4.00
(+620.9 pct) (-81.4 pct) (+136.4 pct)
Net 1.80 26.19 2.60
(-93.1 pct) (-90.5 pct)
EPS 64.14 yen 933.34 yen 92.60 yen
EPS Diluted 64.13 yen
Ann Div 48.00 yen 48.00 yen
-Q2 div 24.00 yen 24.00 yen
-Q4 div 24.00 yen 24.00 yen
NOTE - Torii Pharmaceutical Co Ltd.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4551.T
Recent news on Torii Pharmaceutical Co
See all newsTable: Torii Pharmaceutical - 6-MTH parent results
Brief: Torii Pharmaceutical Co Ltd Says It Will Retire Treasury Shares Worth 2.39% Of Outstanding Stock On Aug 29
Deals of the day-Mergers and acquisitions
Deals of the day-Mergers and acquisitions
Drugmaker Shionogi to buy Japan Tobacco's unit Torii Pharmaceutical for $1 billion (updated)